Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Sangamo BioSciences, Inc. (SGMO)

« Back to company index

SGMO Chatter Timeline

Stock Ticker for SGMO

Most Active Tweeters for SGMO

UserTweets
@BiotechAnalysst 12
@mchilberg 8
@mattyjc 3
@TradeWithAlerts 3
@MarcJacksonLA 2

Recent Tweets for SGMO

Gambiste1 @Gambiste1
RT @wkissel: $SGMO Pfizer and Sangamo re-open PhIII of hemophilia A gene therapy; AEON headed to PhIII - https://t.co/aVWTLen5vb
September 24th 2022, 1:09am
wkissel @wkissel
$SGMO Pfizer and Sangamo re-open PhIII of hemophilia A gene therapy; AEON headed to PhIII - https://t.co/aVWTLen5vb
September 24th 2022, 12:09am
Tickeron @Tickeron
$SGMO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/NyGLuBM6T9
September 23rd 2022, 9:09pm
TradeWithAlerts @TradeWithAlerts
Nice print for $SGMO Size: 239390 Price: 4.95 Amount: $1,184,980.50 Time: 1600 See more: https://t.co/hnsHyqewlx Jo… https://t.co/ua5J63XJqN
September 23rd 2022, 8:09pm
MarcJacksonLA @MarcJacksonLA
$PFE $SGMO Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial https://t.co/LojIdpJCHq
September 23rd 2022, 2:09pm
john_bresnahan @john_bresnahan
RT @BullBearBres: $PFE & $SGMO ?? Pfizer & Sangamo Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Opened R…
September 23rd 2022, 4:09am
BullBearBres @BullBearBres
$PFE & $SGMO ?? Pfizer & Sangamo Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Op… https://t.co/2oJ8TDrTKP
September 23rd 2022, 4:09am
MarcJacksonLA @MarcJacksonLA
$PFE $SGMO Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A… https://t.co/f65Ccbvw1w
September 23rd 2022, 1:09am
BiotechAnalysst @BiotechAnalysst
RT @MarketCurrents: $PFE $SGMO - Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy https://t.co/9mzV2BHx…
September 22nd 2022, 11:09pm
MarketCurrents @MarketCurrents
$PFE $SGMO - Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy https://t.co/9mzV2BHxya
September 22nd 2022, 9:09pm
quantisnow @quantisnow
$SGMO ? Sangamo Therapeutics Inc. filed SEC Form 8-K: Other Events https://t.co/zS7y0gDVEO 45 seconds delayed.
September 22nd 2022, 9:09pm
TradeWithAlerts @TradeWithAlerts
Nice print for $SGMO Size: 161897 Price: 5.04 Amount: $815,960.88 Time: 1600 See more: https://t.co/hnsHyqewlx Join… https://t.co/usVfFgDcT1
September 22nd 2022, 8:09pm
BiotechAnalysst @BiotechAnalysst
RT @BiotechAnalysst: Buying $sgmo sub 5 !
September 22nd 2022, 6:09pm
BiotechAnalysst @BiotechAnalysst
RT @BiotechAnalysst: $SGMO Fabry trial updated too: expanding into Australia, Italy, Canada Experimental: Expansion Cohorts Anti Alpha…
September 22nd 2022, 6:09pm
BiotechAnalysst @BiotechAnalysst
$SGMO Fabry trial updated too: expanding into Australia, Italy, Canada Experimental: Expansion Cohorts Anti Al… https://t.co/abrBdPfn7p
September 22nd 2022, 4:09pm
BiotechAnalysst @BiotechAnalysst
Buying $sgmo sub 5 ! https://t.co/J4ABtE29oA
September 22nd 2022, 1:09pm
BiotechObserver @BiotechObserver
@kernytsky @NatHarooni This thread doesn't concern $SGMO or them needing to get anything right, though lol
September 22nd 2022, 12:09am
kernytsky @kernytsky
@NatHarooni @BiotechObserver That combined with $SGMO sputtering around for 20 years and producing nothing despite… https://t.co/w4Dnn8iq5y
September 22nd 2022, 12:09am
mattyjc @mattyjc
@mchilberg That sirolimus and rituximab combo will make it very, very hard to for $FDMT to be competitive if $SGMO… https://t.co/cjuAfK3RdP
September 21st 2022, 12:09pm
BenzingaMedia @BenzingaMedia
$PLX, $SGMO Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform - https://t.co/xtlZq2Snwd
September 20th 2022, 12:09pm
newsfilterio @newsfilterio
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $SGMO https://t.co/CqT4c7pv5L
September 19th 2022, 11:09pm
FlashAlert_me @FlashAlert_me
$SGMO [15s. delayed] filed SEC form 3: SVP-Chief Development Officer Dubois-Stringfellow Nathalie: https://t.co/q0fsslasME
September 19th 2022, 11:09pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $SGMO $PRCH ... https://t.co/aW7zteLmZs
September 19th 2022, 4:09pm
Gregory96452458 @Gregory96452458
$SGMO is set and ready for a run up:~ ? https://t.co/3QMEpMlx5p
September 19th 2022, 8:09am
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: Well said. $SGMO TF regulation and novel delivery are both progressing nicely under the radar. Time will tell but as $NTLA…
September 16th 2022, 4:09pm
mchilberg @mchilberg
Well said. $SGMO TF regulation and novel delivery are both progressing nicely under the radar. Time will tell but… https://t.co/Rx7hfv5y98
September 16th 2022, 4:09pm
mattyjc @mattyjc
@iamseanmcd @CarterBWorth Oh you’ve heard of my $SGMO hodl strategy, I see? https://t.co/CRlQt9ZcKX
September 16th 2022, 1:09pm
mattyjc @mattyjc
ZFPs for treatment of prion disease (in mice) $SGMO https://t.co/FAQ8gsZl2a
September 15th 2022, 4:09pm
Biotech2050 @Biotech2050
RT @BiotechAnalysst: $SGMO Abstract reducing Prion : " ZF-TFs can substantially lower PrP in the #brain, extend #survival, and #alter disea…
September 15th 2022, 4:09pm
BiotechAnalysst @BiotechAnalysst
$SGMO Abstract reducing Prion : " ZF-TFs can substantially lower PrP in the #brain, extend #survival, and #alter di… https://t.co/i1RjcEYMRn
September 15th 2022, 2:09pm
BiotechAnalysst @BiotechAnalysst
RT @bio_2022: $SGMO another forgotten name just ramp above 30 weeks moving avg and consolidate back to 9 weeks moving avg. A 1st pullback t…
September 15th 2022, 1:09pm
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: Bottom line: $SGMO preliminary data appears very strong and the clinical design has provided an exceptional foundation that…
September 15th 2022, 1:09pm
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: $SGMO ST-920 has completed dose finding studies and is now in cohort expansion. Yesterday SM stated that they decided to eli…
September 15th 2022, 1:09pm
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: $SGMO study appears exceptionally well designed. They have a mix of on-ERT, off-ERT and ERT-naive patients enrolled with ea…
September 15th 2022, 1:09pm
BiotechAnalysst @BiotechAnalysst
$SGMO Gene Therapy for Adults with Severe Hemophilia A, to Provide Substantial #Cost #Savings Per Patient
September 15th 2022, 1:09pm
bio_2022 @bio_2022
$SGMO another forgotten name just ramp above 30 weeks moving avg and consolidate back to 9 weeks moving avg. A 1st… https://t.co/zGqdgs2F1t
September 15th 2022, 7:09am
mchilberg @mchilberg
$SGMO has minimized the possibility of accel approval. $VRTX discussion recently on VX147 for APOL-1 is worth a li… https://t.co/k7EqJhdMAX
September 14th 2022, 10:09pm
mchilberg @mchilberg
Bottom line: $SGMO preliminary data appears very strong and the clinical design has provided an exceptional founda… https://t.co/KBTuWnhZVK
September 14th 2022, 10:09pm
mchilberg @mchilberg
One focus point worth watching is the data on kidney/cardiac disease biomarkers eGFR and cMRI LVM. $SGMO has a Kid… https://t.co/vivynKDUfP
September 14th 2022, 10:09pm
mchilberg @mchilberg
A recap of the $SGMO study readouts is attached. Later this year we should get some substantive data on cohort 3-4… https://t.co/M5YLHq3YAW
September 14th 2022, 10:09pm
mchilberg @mchilberg
$SGMO study appears exceptionally well designed. They have a mix of on-ERT, off-ERT and ERT-naive patients enrolle… https://t.co/SDINhiyiEW
September 14th 2022, 10:09pm
mchilberg @mchilberg
$SGMO ST-920 has completed dose finding studies and is now in cohort expansion. Yesterday SM stated that they decid… https://t.co/rQvZVo10Lg
September 14th 2022, 10:09pm
TradeWithAlerts @TradeWithAlerts
Nice print for $SGMO Size: 632849 Price: 5.59 Amount: $3,537,625.91 Time: 1600 See more: https://t.co/hnsHyqewlx Jo… https://t.co/GIhZj1KCB5
September 14th 2022, 8:09pm
ChartMill @ChartMill
$SGMO is expected to show quite a strong growth in Revenue, Revenue will grow by 10.45% yearly.… https://t.co/fJ8pPnA0J9
September 14th 2022, 12:09pm
mchilberg @mchilberg
$SGMO at HC Wainwright today. Mostly a repeat https://t.co/iKMIgqWmWI
September 12th 2022, 6:09pm
SwingTradeBot @SwingTradeBot
20 DMA Support today: $SGMO $NRSN ... https://t.co/deOpbNqLGE
September 9th 2022, 7:09pm
Tickeron @Tickeron
$SGMO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/66Alieqsog
September 2nd 2022, 6:09pm
SADIFAnalytics @SADIFAnalytics
Will Sangamo Therapeutics Inc Deliver Top-Shelf Performance? $SGMO https://t.co/PZiBWo0qWE
September 2nd 2022, 3:09pm
MitchellReed09 @MitchellReed09
RT @mchilberg: Next step to enroll 6 participants in 6 different cohorts??? Need to fact check this article $SGMO
September 2nd 2022, 2:09pm
mchilberg @mchilberg
Next step to enroll 6 participants in 6 different cohorts??? Need to fact check this article $SGMO https://t.co/NEm05T7jqb
September 2nd 2022, 1:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.